Imagenebio Stock Technical Analysis
| IMA Stock | 7.51 0.18 2.46% |
As of the 2nd of February, ImageneBio retains the Risk Adjusted Performance of (0.01), market risk adjusted performance of (0.12), and Standard Deviation of 3.74. ImageneBio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
ImageneBio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ImageneBio, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImageneBioImageneBio | Build AI portfolio with ImageneBio Stock |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImageneBio. Market participants price ImageneBio higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ImageneBio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
ImageneBio's market price often diverges from its book value, the accounting figure shown on ImageneBio's balance sheet. Smart investors calculate ImageneBio's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since ImageneBio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between ImageneBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImageneBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImageneBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ImageneBio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ImageneBio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ImageneBio.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in ImageneBio on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding ImageneBio or generate 0.0% return on investment in ImageneBio over 90 days. ImageneBio is related to or competes with Connect Biopharma, InflaRx NV, Kalaris Therapeutics, Shattuck Labs, Context Therapeutics, Sutro Biopharma, and Artiva Biotherapeutics. ImageneBio is entity of United States. It is traded as Stock on NASDAQ exchange. More
ImageneBio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ImageneBio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ImageneBio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 16.1 | |||
| Value At Risk | (5.08) | |||
| Potential Upside | 6.76 |
ImageneBio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ImageneBio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ImageneBio's standard deviation. In reality, there are many statistical measures that can use ImageneBio historical prices to predict the future ImageneBio's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (0.13) |
ImageneBio February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 2.68 | |||
| Coefficient Of Variation | (4,008) | |||
| Standard Deviation | 3.74 | |||
| Variance | 14.0 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 16.1 | |||
| Value At Risk | (5.08) | |||
| Potential Upside | 6.76 | |||
| Skewness | 1.23 | |||
| Kurtosis | 2.53 |
ImageneBio Backtested Returns
ImageneBio holds Efficiency (Sharpe) Ratio of -0.0227, which attests that the entity had a -0.0227 % return per unit of risk over the last 3 months. ImageneBio exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out ImageneBio's Risk Adjusted Performance of (0.01), standard deviation of 3.74, and Market Risk Adjusted Performance of (0.12) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.81, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, ImageneBio's returns are expected to increase less than the market. However, during the bear market, the loss of holding ImageneBio is expected to be smaller as well. At this point, ImageneBio has a negative expected return of -0.0849%. Please make sure to check out ImageneBio's potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if ImageneBio performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.68 |
Very good reverse predictability
ImageneBio has very good reverse predictability. Overlapping area represents the amount of predictability between ImageneBio time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ImageneBio price movement. The serial correlation of -0.68 indicates that around 68.0% of current ImageneBio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.68 | |
| Spearman Rank Test | -0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.25 |
ImageneBio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ImageneBio Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ImageneBio volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About ImageneBio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ImageneBio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ImageneBio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ImageneBio price pattern first instead of the macroeconomic environment surrounding ImageneBio. By analyzing ImageneBio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ImageneBio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ImageneBio specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2025 | 2026 (projected) | Interest Debt Per Share | 0.26 | 0.18 | 0.17 | Revenue Per Share | 0.22 | 0.0834 | 0.0792 |
ImageneBio February 2, 2026 Technical Indicators
Most technical analysis of ImageneBio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ImageneBio from various momentum indicators to cycle indicators. When you analyze ImageneBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 2.68 | |||
| Coefficient Of Variation | (4,008) | |||
| Standard Deviation | 3.74 | |||
| Variance | 14.0 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 16.1 | |||
| Value At Risk | (5.08) | |||
| Potential Upside | 6.76 | |||
| Skewness | 1.23 | |||
| Kurtosis | 2.53 |
ImageneBio February 2, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ImageneBio stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.04 | ||
| Daily Balance Of Power | 0.56 | ||
| Rate Of Daily Change | 1.02 | ||
| Day Median Price | 7.44 | ||
| Day Typical Price | 7.46 | ||
| Price Action Indicator | 0.16 | ||
| Market Facilitation Index | 0.32 |
Complementary Tools for ImageneBio Stock analysis
When running ImageneBio's price analysis, check to measure ImageneBio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImageneBio is operating at the current time. Most of ImageneBio's value examination focuses on studying past and present price action to predict the probability of ImageneBio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImageneBio's price. Additionally, you may evaluate how the addition of ImageneBio to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |